Mesa Laboratories, Inc.
Balance Sheet
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $26.9M | $27.3M | $28.2M | $32.9M | $49.3M | $263.9M | $81.4M | $10.2M |
| Accounts Receivable | $44.1M | $42.0M | $39.1M | $42.6M | $41.2M | $23.8M | $21.1M | $12.5M |
| Inventory | $26.4M | $25.4M | $32.7M | $34.6M | $24.6M | $11.2M | $14.2M | $6.8M |
| Total Current Assets | $106.3M | $102.7M | $109.4M | $119.0M | $124.3M | $303.7M | $122.8M | $33.6M |
| Property, Plant & Equipment | $30.6M | $32.3M | $31.8M | $28.1M | $28.6M | $22.0M | $22.1M | $22.2M |
| Goodwill | $186.9M | $181.8M | $180.1M | $286.4M | $291.2M | $160.8M | $141.5M | $66.4M |
| Intangible Assets (Excl. Goodwill) | $83.3M | $96.9M | $113.8M | $216.8M | $250.1M | $111.7M | $119.9M | $33.2M |
| Total Assets | $427.7M | $433.3M | $446.8M | $661.8M | $707.4M | $601.5M | $409.1M | $156.8M |
| Liabilities | ||||||||
| Accounts Payable | $4.9M | $5.7M | $6.0M | $6.1M | $7.9M | $4.5M | $3.4M | $2.9M |
| Total Current Liabilities | $61.9M | $164.0M | $44.3M | $43.4M | $48.1M | $32.6M | $26.0M | $23.7M |
| Long-Term Debt | $67.5M | $71.3M | — | — | — | — | — | $20.6M |
| Total Liabilities | $241.5M | $273.5M | $301.4M | $268.4M | $313.6M | $195.2M | $189.1M | $45.5M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-185.7M | $-188.9M | $-183.5M | $74.2M | $76.7M | $72.5M | $72.4M | $73.3M |
| Total Stockholders' Equity | $186.2M | $159.8M | $145.4M | $393.5M | $393.8M | $406.2M | $220.0M | $111.3M |